The Missing Piece in the Dark Metabolome Puzzle? - Top-Institutions - MDSpire

The Missing Piece in the Dark Metabolome Puzzle?

Microdroplets formed during electrospray ionization may trigger chemical reactions that help explain a substantial portion of the “dark metabolome” – though some researchers question their relevance under typical metabolomics conditions

  • By

  • James Strachan

  • April 8, 2026

  • 12 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    Stanford University
    Stanford University

    Stanford, CA

    Key Differentiators

    • Analytical Chemistry
    • Metabolomics
    • Mass Spectrometry

  • #2

    The Scripps Research Institute
    The Scripps Research Institute

    La Jolla, CA

    Key Differentiators

    • Metabolomics
    • Chemical Biology
    • Mass Spectrometry

  • #3

    University of California, San Diego (UCSD)
    University of California, San Diego (UCSD)

    La Jolla, CA

    Key Differentiators

    • Metabolomics
    • Mass Spectrometry
    • Systems Biology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Metabolomics
    • Analytical Chemistry
    • Biomedical Research

  • #5

    Tsinghua University
    Tsinghua University

    Beijing, Beijing

    Key Differentiators

    • Analytical Chemistry
    • Mass Spectrometry
    • Metabolomics

Original Source(s)

The Missing Piece in the Dark Metabolome Puzzle?

  • by James Strachan

  • April 8, 2026

Related Content

Deep-UV Raman Reveals mRNA Encapsulation in Lipid Nanoparticles 

Spectroscopic analysis reveals lipid–RNA interactions governing nanoparticle formulation efficiency 

  • March 13, 2026

  • 2 min
How Metal Imbalance Rewires Metabolism 

Integrated metallomics and metabolomics map metabolic responses to metal imbalance

  • February 25, 2026

  • 2 min
Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency